MedPath

Can Virtual Reality Reduce Depression and Agitation in Older Adults With Moderate to Severe Dementia?

Not Applicable
Conditions
Moderate Dementia
Severe Dementia
Registration Number
NCT04347668
Lead Sponsor
Western University, Canada
Brief Summary

Dementia is a term used to describe a collection of symptoms including memory loss, problems with reasoning and communication, and a reduction in a person's ability to carry out daily activities. The most common types of dementia are: Alzheimer's disease, vascular dementia, mixed dementia and dementia with Lewy bodies. Clinicians and families are looking for ways to deal with this challenging group of diseases to improve quality of life, reduce depression and agitation for individuals in long term care (LTC).

There are a variety of non-pharmacologic interventions for dementia often used in addressing physiological and behavioral challenges, new to this category of treatment is virtual reality (VR).

Virtual reality has been studied in mild cognitive impairment. Colleagues completed a systematic review of non-pharmacological intervention to treat older people with dementia and found music to be the only intervention effective, VR was not included as no studies were found.

The Registered Nurses Association of Ontario report non-pharmacological approaches are an important alternative to the use of antipsychotic medications. They recommend health-care providers should consider non-pharmacological interventions wherever possible as a first-line approach to the management of BPSD.

Virtual reality as proposed in this research will include music, library items will be selected that are person specific, and will provide sensory stimulation. To date there is no published research on the use the VR in moderate to severe dementia in LTC, looking at depression.

Detailed Description

Dementia is a term used to describe a collection of symptoms including memory loss, problems with reasoning and communication, and a reduction in a person's ability to carry out daily activities such as washing, dressing and cooking. The most common types of dementia are: Alzheimer's disease, vascular dementia, mixed dementia and dementia with Lewy bodies. Dementia is a progressive condition, which means that the symptoms will gradually get worse. Clinicians and families are looking for ways to deal with this challenging group of diseases to improve quality of life, reduce depression and agitation that often accompany dementia as it progresses and individuals are placed in long term care (LTC).

There are a variety of non-pharmacologic interventions for dementia ranging from traditional interventions such as behavioral therapy to newer interventions such as multisensory therapy. Often used in addressing physiological and behavioral challenges, some interventions have been shown to aid cognitive ability as well. "Cognitive stimulation," is a catchall term referring to non-pharmacologic interventions with a cognitive focus, new to this category of treatment is virtual reality (VR).

Virtual reality has been studied in mild cognitive impairment. A systematic review of studies evaluating computerized cognitive training and virtual reality cognitive training interventions for individuals at high risk of cognitive decline called mild cognitive decline documented consistent improvement in the domains of attention, executive function, visual and verbal memory, and also on the psychological symptoms of depression, anxiety, and apathy in participants. Colleagues completed a systematic review of non-pharmacological intervention to treat older people with dementia and found music to be the only intervention effective, VR was not included as no studies were found.

The Registered Nurses Association of Ontario completed a best practice guideline on Dementia based on current evidence in 2016. They report non-pharmacological approaches are an important alternative to the use of antipsychotic medications, which historically have been overused as a first-line strategy for managing behavioural and psychological systems of dementia (BPSD). They recommend health-care providers should consider non-pharmacological interventions wherever possible as a first-line approach to the management of BPSD.

The most well-studied and effective non-pharmacological approaches include listening to music/music therapy, effective communication and person-centred approaches and other sensory stimulation. Virtual reality as proposed in this research will include music, specific library items will be selected that are person specific, and will provide sensory stimulation in keep with the RNAO guidelines. To date there is no published research on the use the VR in moderate to severe dementia in LTC looking at depression as the primary outcome measure.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
266
Inclusion Criteria
  1. Resident of Henley Place, Henley House, and Burton Manor
  2. Cognitive Performance Scale score between 3 to 5.
Exclusion Criteria
  1. Without a medical diagnosis of dementia,
  2. Diagnosis of epilepsy,
  3. Those who are blind,
  4. Residents at end of life,
  5. Unable to communicate in English,
  6. Residents whose substitute decision-maker is from the Public Trustee and Guardian office of Ontario.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Cornell Scale for DepressionThis will be completed weekly to compare this to the change from baseline over a 2 week period.

The Cornell Scale for Depression is a 19 item scale that measures depression where a score of 12 or above indicates probable depression.

Secondary Outcome Measures
NameTimeMethod
Percentage SleepThis will be completed weekly to compare this to the change from baseline over a 2 week period.

This is currently recorded in the participants electronic chart by the night staff.

WeightWeight will be recorded before and after the intervention to compare the change from baseline over a 2 month period.

From the chart we will record the weights of the participants

1 to 1 staffWe will record from administrative data the hours of 1 to 1 staff per participant, for 1 month, before and after the intervention. This will be completed monthly to compare this to the change from baseline over a 2 month period.

We will record the number of hours of 1 to 1 staff usage to manage behaviours.

Transfers to the emergency department (ED)We will record from the chart the transfer to the emergency department per participant, for 1 month, before and after the intervention. This will be completed monthly to compare this to the change from baseline over a two month period.

From the chart we will record and transfers to the ED for catastrophic behaviours.

Psychotropic medicationThis will be completed weekly to compare this to the change from baseline over a 2 week period.

From the chart we will record the use of psychotropic medications, both regular dose and prn's

The Cohen Mansfield Agitation InventoryThis will be completed weekly to compare this to the change from baseline over a 2 week period.

The Cohen-Mansfield Agitation Inventory (CMAI; (Cohen-Mansfield and Kerin, 1986)) is a 29-item tool (Cohen-Mansfield et al., 1989) developed to assess agitated behaviours of people residing within nursing homes.

Trial Locations

Locations (3)

Burton Manor

🇨🇦

Brampton, Ontario, Canada

Henley Place

🇨🇦

London, Ontario, Canada

Henley House

🇨🇦

St. Catherines, Ontario, Canada

Burton Manor
🇨🇦Brampton, Ontario, Canada
© Copyright 2025. All Rights Reserved by MedPath